AI to predict multiple myeloma outcomes from old data
NCT ID NCT07283224
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study looks at information already collected from 600 people with multiple myeloma. Researchers will combine genetic, clinical, and imaging data to train artificial intelligence models. The goal is to find patterns that could help predict how the disease will progress and how patients might respond to treatment. No new tests or visits are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA MULTIPLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS AOU Policlinico Sant'Orsola
RECRUITINGBologna, Bo, 40138, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.